---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-015242"
form_type: "8-K"
ticker: "NGTF"
cik: "0001593001"
company_name: "NightFood Holdings, Inc."
filed_at: "2026-04-06T23:59:59+00:00"
generated_at: "2026-05-15T07:19:06.460406+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nightfood (NGTF) subsidiary TechForce Robotics enters joint development deal with Oncotelic (OTLC) for pharma robotics

## Summary
- TechForce Robotics and Oncotelic will jointly develop AI-enabled, GMP-compliant robotic systems for pharma manufacturing.
- Agreement term: initial 1 year, auto-renewing for 5-year terms unless terminated.
- IP: AI foreground owned by Oncotelic; robotic hardware owned by TechForce; jointly developed IP jointly owned; all data owned by TechForce.
- Revenue sharing, royalty, and profit terms to be negotiated in a separate Commercialization Agreement before first commercial sale.
- TechForce is wholly owned by Nightfood Holdings (NGTF); Oncotelic trades as OTLC.

## SEC filing metadata
- accession: 0001493152-26-015242
- form_type: 8-K
- ticker: NGTF
- cik: 0001593001
- company_name: NightFood Holdings, Inc.
- filed_at: 2026-04-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593001/000149315226015242/0001493152-26-015242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593001/000149315226015242/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-015242
- JSON: https://secwatch.observer/filing/0001493152-26-015242.json
- Plain text: https://secwatch.observer/filing/0001493152-26-015242.txt

## Source-grounded claims
- claim_id: bec4a95454b26fec31311fee086a062ff4b5a669
  claim: NightFood Holdings, Inc. entered into Joint Development, Manufacturing and Licensing Agreement with Oncotelic Therapeutics, Inc. (effective 2026-03-31).
  evidence_excerpt: On March 31, 2026, Nightfood Holdings, Inc. (the “Company”), wholly owned subsidiary, TechForce Robotics, Inc. (“TechForce”), entered into a Joint Development, Manufacturing and Licensing Agreement (the “Agreement”) with Oncotelic Therapeutics, Inc., (“Oncotelic”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1593001/000149315226015242/0001493152-26-015242-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.